Literature DB >> 18967053

The degree of deacetylation of chitosan: advocating the first derivative UV-spectrophotometry method of determination.

S C Tan1, E Khor, T K Tan, S M Wong.   

Abstract

The degree of deacetylation (DD) is increasingly becoming an important property for chitosan, as it determines how the biopolymer can be applied. Therefore, a simple, rapid and reliable method of determining the DD for chitosan is essential. In this report, the DD of chitosan was determined by nuclear magnetic resonance (NMR), linear potentiometric titration (LPT), ninhydrin test and first derivative UV-spectrophotometry (1DUVS). The DD was calculated on a per mol basis instead of on a per mass basis. This is important as the molecular weights of N-acetyl-d-glucosamine and d-glucosamine are different. By converting the mass of N-acetyl-d-glucosamine and d-glucosamine into mols and calculating for the percentage of d-glucosamine present in the chitosan sample, a more accurate estimation of the DD can be obtained. Of the four methods, there is good correlation between 1DUVS and NMR. The concentration of chitosan solution for 1DUVS analysis was standardised as 0.1000 mg chitosan per ml of 0.0100 M acetic acid solution. The presence of d-glucosamine was corrected for by a reference curve for N-acetyl-d-glucosamine. 1DUVS is easy to perform, sensitive and the interference of other contaminants to the results is minimal compared with the other three methods. Therefore, we advocate 1DUVS to be used as the standard methods for routine determination of DD of chitosan.

Entities:  

Year:  1998        PMID: 18967053     DOI: 10.1016/s0039-9140(97)00288-9

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  20 in total

1.  Use of chitosan membrane from the carapace of the soldier crab Mictyris brevidactylus for biosensor construction.

Authors:  Bo-Chuan Hsieh; Tzong-Jih Cheng; Tzu-Yu Wang; Richie L C Chen
Journal:  Mar Biotechnol (NY)       Date:  2003 Mar-Apr       Impact factor: 3.619

2.  Uptake of FITC-chitosan nanoparticles by A549 cells.

Authors:  Min Huang; Zengshuan Ma; Eugene Khor; Lee-Yong Lim
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

3.  Impact of structurally modifying hyaluronic acid on CD44 interaction.

Authors:  D Bhattacharya; D Svechkarev; J J Souchek; T K Hill; M A Taylor; A Natarajan; A M Mohs
Journal:  J Mater Chem B       Date:  2017-09-20       Impact factor: 6.331

4.  Porous-conductive chitosan scaffolds for tissue engineering II. in vitro and in vivo degradation.

Authors:  Ying Wan; Aixi Yu; Hua Wu; Zhaoxu Wang; Dijiang Wen
Journal:  J Mater Sci Mater Med       Date:  2005-11       Impact factor: 3.896

5.  Synthesis, characterization and anticancer activity of tanshinone I grafted low molecular chitosan.

Authors:  Dongdong Wang; Yuelin Sun; Yuanyuan Wu; Lili Ma; Jinyou Duan
Journal:  Glycoconj J       Date:  2016-09-15       Impact factor: 2.916

Review 6.  Application of spectroscopic methods for structural analysis of chitin and chitosan.

Authors:  Jolanta Kumirska; Małgorzata Czerwicka; Zbigniew Kaczyński; Anna Bychowska; Krzysztof Brzozowski; Jorg Thöming; Piotr Stepnowski
Journal:  Mar Drugs       Date:  2010-04-29       Impact factor: 5.118

7.  Nonviral gene delivery from nonwoven fibrous scaffolds fabricated by interfacial complexation of polyelectrolytes.

Authors:  Shawn H Lim; I-Chien Liao; Kam W Leong
Journal:  Mol Ther       Date:  2006-02-23       Impact factor: 11.454

Review 8.  Polysaccharide-based nanoparticles for theranostic nanomedicine.

Authors:  M Swierczewska; H S Han; K Kim; J H Park; S Lee
Journal:  Adv Drug Deliv Rev       Date:  2015-11-27       Impact factor: 15.470

9.  Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation.

Authors:  Min Huang; Eugene Khor; Lee-Yong Lim
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

Review 10.  Chitosans for delivery of nucleic acids.

Authors:  Michael D Buschmann; Abderrazzak Merzouki; Marc Lavertu; Marc Thibault; Myriam Jean; Vincent Darras
Journal:  Adv Drug Deliv Rev       Date:  2013-07-18       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.